Table 4.
Author | Study | Treatment | Serum urate |
Comments | |
---|---|---|---|---|---|
Control | Treated; p value |
||||
Cherries and anthocyanins
versus
control (or before and after)
Animal studies | |||||
Haidari et al.77 | Animal model examining the effect of tart cherry juice on SU, xanthine oxidoreductase activity, and markers of oxidative stress in rats | 14 days of oral tart cherry juice (5 ml/kg) | Hyperuricemic control 214.36 ± 26.42 μmol/l (3.60 ± 0.44 mg/dl) |
171.95 ± 25.78 μmol/l (2.89 ± 0.43 mg/dl); p ⩽ 0.05 |
XO inhibited by 20% SU after 14 days of allopurinol (5 mg/kg) was 72.38 ± 19.24 μmol/l (1.22 ± 0.32 mg/dl), with 58% XO inhibition |
Hwa et al.79 | Animal model examining the hypouricemic effects of anthocyanin extracts from purple sweet potato (APSP) extract on hyperuricemic mice | Single dose of 100 mg/kg of APSP | Hyperuricemic control 10.25 ± 0.63 mg/dl | 4.1 ± 0.04 mg/d; p < 0.01 |
Reduction of 60% in SU One dose of allopurinol 10 mg/kg reduced SU to 1.84 ± 0.13 mg/dl (82%) |
Tsai et al.80 | Animal model exploring the antitumor effect of anthocyanin extract from Hibiscus sabdariffa in leukemic rats | Hibiscus anthocyanin extract at 0.2 g/kg/day for 220 days | Leukemic rat control 3.07 ± 0.89 mg/dl | 0.87 ± 0.22 mg/dl; p < 0.005 |
Reduction of 72% in SU Significant SU reduction (p < 0.05) also seen in rats treated with 0.1 g/kg/d |
Zhang et al.81 | Animal model examining the effects of anthocyanin-rich purple sweet potato extract (APSPE) on XO activity in vitro/ in vivo, as well as SU in hyperuricemic mice | Single dose of 300 mg/kg of APSP (anthocyanin content of 3.53 × 10⁴ cyanidin 3-glucoside equivalent per 100 g APSPE) | Hyperuricemic control 134.67 μmol/l (2.26 mg/dl) | 95.50 μmol/l (1.61 mg/dl); p < 0.001 |
Reduction of 29% in SU Positive control with allopurinol 5 mg/kg lowered SU to nearly undetectable level Significant inhibitory activity on XO |
Human studies | |||||
Bell et al.26 | Single-blind, two-phase, randomized, crossover study examining the effects of tart cherries on urate activity and inflammation in 12 healthy participants | Montmorency tart cherry juice concentrate at 30 or 60 ml (30 ml tart cherry juice ~90 cherries) | Baseline: ~494 µmol/l (8.3046 mg/dl) | 8 hr postsupplementation: ~316 µmol/l (5.31 mg/dl); p < 0.0001 |
Reduction of 36% (178 µmol/l/ 2.99 mg/dl) in SU, 250% (178 μmol/mmol creatinine) increase in urinary urate at 2 h Change independent of dose |
Jacob et al.78 | Examining the effects of cherry consumption on plasma urate, antioxidant, and inflammatory markers in 10 healthy women | 280 g of sweet Bing cherries (~45 cherries) | Baseline: 214 ± 13 μmol/l (3.60 ± 0.22 mg/dl) |
5 h postcherry consumption: 183 ± 15 μmol/l (3.07± 0.25 mg/dl); p <0.05 |
Reduction of 14% in SU Urinary urate increased from 202 ± 13 to 350 ± 33 μmol/mmol creatinine (73%) after 3 h |
Schlesinger et al.25 | Randomized controlled trial of cherry versus pomegranate juice concentrate for gout prophylaxis in 14 patients with crystal-proven gout | 1 Tbsp (~45–60 cherries) of cherry juice concentrate twice daily for 4 months | Pomegranate juice 7.45 ± 1.62 to 6.14 ± 1.07 mg/dl |
Cherry juice 8.37 ± 0.82 to 8.17 ± 1.1 mg/dl; p value not provided |
No significant change in serum urate |
Schlesinger et al.25 | Retrospective study evaluating cherry juice concentrate, taken for over 4 months, on gout flare prophylaxis in 24 crystal-proven gout patients | 1 Tbsp (~45–60 cherries) of cherry juice concentrate twice daily for 4–6 months | Baseline: 9.0 ± 1.1 mg/dl |
After cherry juice: 8.7 ± 1.4 mg/dl; p = 0.5943 |
Baseline SU in patients receiving allopurinol was 8.4 ± 0.6 mg/dl and decreased to 6.2 ± 0.4 mg/dl (p = 0.0052) |
APSP, anthocyanin extracts from purple sweet potato; APSPE, anthocyanin-rich purple sweet potato extract; Tbsp, tablespoon; SU, serum urate; XO, xanthine oxidase.